Also known as: 19-nor-1,25-(OH)2 vitamin D2; Zemplar; Abbott-75828
Paricalcitol is a synthetic vitamin D analogue used to prevent and treat secondary hyperparathyroidism associated with chronic kidney disease (CKD). Manufactured by Mediocon Inc in Aurangabad, Maharashtra, India at a GMP-certified facility. CAS No: 131918-61-1.
| Parameter | Specification |
|---|---|
| CAS Number | 131918-61-1 |
| Molecular Formula | C27H44O3 |
| Molecular Weight | 416.64 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Vitamin D Analogue / Secondary Hyperparathyroidism Agent |
| Appearance | White powder |
| Solubility | Practically insoluble in water; soluble in ethanol and propylene glycol |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2030 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Paricalcitol — CAS 131918-61-1 (CAS 131918-61-1) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Paricalcitol — CAS 131918-61-1 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance